Table 3 Baseline patient characteristics of individuals with ischemic stroke after PSM
Characteristics | Adverse Outcome (+) (n = 486) | Adverse Outcome (−) (n = 486) | P-value |
|---|---|---|---|
Patient status | |||
Age, years | 74 (61, 83) | 75 (65, 83) | 0.384 |
Sex male, n (%) | 331 (68.11%) | 339 (69.75%) | 0.579 |
Smoker, n (%) | 173 (35.60%) | 177 (36.42%) | 0.789 |
Drinker, n (%) | 114 (23.46%) | 109 (22.43%) | 0.703 |
SBP, mmHg | 123 (110, 139) | 123.5 (109, 139.75) | 0.761 |
DBP, mmHg | 71 (63, 84) | 71 (63, 81) | 0.501 |
Comorbidities | |||
Diabetes, n (%) | 171 (35.19%) | 176 (36.21%) | 0.738 |
Hypertension, n (%) | 327 (67.28%) | 336 (69.14%) | 0.535 |
CHD, n (%) | 318 (65.43%) | 304 (62.55%) | 0.350 |
CKD, n (%) | 154 (31.69%) | 158 (32.51%) | 0.783 |
CRD, n (%) | 386 (79.42%) | 393 (80.86%) | 0.574 |
Treatment | |||
Thrombolytic, n (%) | 15 (3.09%) | 8 (1.65%) | 0.140 |
Insulin use, n (%) | 243 (50.00%) | 225 (46.30%) | 0.248 |
Oxygen therapy, n (%) | 224 (46.09%) | 219 (45.06%) | 0.747 |
Fat-related indicators | |||
BMI, kg/m2 | 23.9 (23, 24.7) | 24 (23.2, 24.7) | 0.693 |
BFP, % | 31.7 (28.5, 36.3) | 31.6 (28.7, 35.5) | 0.996 |
TC, mmol/L | 4.60 (3.93, 5.59) | 4.51 (3.82, 5.30) | 0.033 |
TG, mmol/L | 1.71 (1.17, 2.4) | 1.47 (1.02, 2.13) | <0.001 |
HDL, mmol/L | 1.12 (0.95, 1.39) | 1.12 (0.95, 1.32) | 0.569 |